Evidence map›Paper›PMID 29454519›Full record

ArticleVaccine2018

High resolution age-structured mapping of childhood vaccination coverage in low and middle income countries.

C Edson Utazi, Julia Thorley, Victor A Alegana, Matthew J Ferrari, Saki Takahashi, C Jessica E Metcalf, Justin Lessler, Andrew J Tatem

Abstract read
In one paragraph

Article in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

C Edson UtaziWorldPop, Department of Geography and Environment, University of Southampton, Southampton SO17 1BJ, UK; Southampton Statistical Sciences Research Institute, University of Southampton, Southampton SO17 1BJ, UK. Electronic address: c.e.utazi@soton.ac.uk.
Julia ThorleyWorldPop, Department of Geography and Environment, University of Southampton, Southampton SO17 1BJ, UK.
Victor A AleganaWorldPop, Department of Geography and Environment, University of Southampton, Southampton SO17 1BJ, UK; Flowminder Foundation, Stockholm SE-11355, Sweden.
Matthew J FerrariCenter for Infectious Disease Dynamics, The Pennsylvania State University, State College, PA 16802, USA.
Saki TakahashiDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA.
C Jessica E MetcalfDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USA.
Justin LesslerDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Andrew J TatemWorldPop, Department of Geography and Environment, University of Southampton, Southampton SO17 1BJ, UK; Flowminder Foundation, Stockholm SE-11355, Sweden.

Funding

Scientific and Technical Computing CoreP2CHD047879 · NICHD · PRINCETON UNIVERSITY · PI SALGANIK, MATTHEW J. · 2014 to 2018
$2.0M
NICHD NIH HHS P2C HD047879Wellcome TrustWellcome Trust 106866/Z/15/Z
6 · The paper itself

Abstract

backgroundThe expansion of childhood vaccination programs in low and middle income countries has been a substantial public health success story. Indicators of the performance of intervention programmes such as coverage levels and numbers covered are typically measured through national statistics or at the scale of large regions due to survey design, administrative convenience or operational limitations. These mask heterogeneities and 'coldspots' of low coverage that may allow diseases to persist, even if overall coverage is high. Hence, to decrease inequities and accelerate progress towards disease elimination goals, fine-scale variation in coverage should be better characterized.

methodsUsing measles as an example, cluster-level Demographic and Health Surveys (DHS) data were used to map vaccination coverage at 1 km spatial resolution in Cambodia, Mozambique and Nigeria for varying age-group categories of children under five years, using Bayesian geostatistical techniques built on a suite of publicly available geospatial covariates and implemented via Markov Chain Monte Carlo (MCMC) methods.

resultsMeasles vaccination coverage was found to be strongly predicted by just 4-5 covariates in geostatistical models, with remoteness consistently selected as a key variable. The output 1 × 1 km maps revealed significant heterogeneities within the three countries that were not captured using province-level summaries. Integration with population data showed that at the time of the surveys, few districts attained the 80% coverage, that is one component of the WHO Global Vaccine Action Plan 2020 targets.

conclusionThe elimination of vaccine-preventable diseases requires a strong evidence base to guide strategies and inform efficient use of limited resources. The approaches outlined here provide a route to moving beyond large area summaries of vaccination coverage that mask epidemiologically-important heterogeneities to detailed maps that capture subnational vulnerabilities. The output datasets are built on open data and methods, and in flexible format that can be aggregated to more operationally-relevant administrative unit levels.

Indexed as

Age FactorsAlgorithmsChildChild, PreschoolDeveloping CountriesGeography, MedicalHumansImmunization ProgramsMarkov ChainsMeaslesMeasles VaccineMonte Carlo MethodPublic Health SurveillanceReproducibility of ResultsSocioeconomic FactorsVaccinationMeasles VaccineVaccinesBayesian geostatisticsCoverage heterogeneitiesDemographic and Health SurveysMeasles vaccine

Identifiers

PMID29454519
PMCPMC6344781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.